Gnosis S.p.A Quatrefolic® NDI Notification Filed by FDA

December, 23th 2010

Gnosis announced today that the Food and Drug Administration (FDA) has accepted a New Dietary Ingredient Notification (NDIN) for the patented ingredient Quatrefolic®, opening the way for the company to sell the product in the United States...

 

Gnosis S.p.A to Make Significant Commitment to its North American Customers with Investment in Commercial Operations Expansion.

December, 1st 2010

Gnosis S.p.A, a European biotechnology company, today announced the expansion of its Commercial Operations into United States and Canada...

 

New Corporate image and Website.

November, 29th 2010

Gnosis S.p.A. is proud to announce the new Corporate image. The image reflects a company that has radically changed in the last 10 years with the conception and construction of the R&D centre and the acquisition of the two operations sites in Switzerland and in Italy...

< Turn back

 

 

 

 

GNOSIS S.P.A. Sede Legale: Piazza del Carmine, 4 20121 Milano. P. IVA 02484720129 C. F. 10197170151 Cap. Soc. 3.000.000,00 € i.v. Registro delle imprese di Milano N° 10197170151